Plain-English translation of NCT04443530 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Coronary Artery Disease research guide →This trial is following patients who receive Ultimaster Tansei or Ultimaster Nagomi stents—small metal tubes placed in blocked heart arteries to improve blood flow. The study watches how well this treatment works and how safe it is in everyday clinical practice, rather than in a controlled research setting.
Doctors want to understand how this medication performs when used in real-world conditions with a wide range of patients, to make sure it's as effective and safe as expected outside of strict research environments.
You likely qualify if…
You likely don't qualify if…
You will receive your stent as part of your normal heart care. After that, you'll be asked to attend scheduled follow-up visits where doctors will monitor how well the stent is working and check for any side effects. The study will collect information about your health over time to evaluate the effectiveness and safety of the treatment.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
South Korea